Effectiveness and Feasibility of Injectable Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study.
Sang-Kyu ImJung-Hee LeeKi Young LeeSeung-Jin YooPublished in: Orthopaedic surgery (2022)
Injectable E-rhBMP-2 will be an effective bone graft substitute when achieving solid interbody fusion in the lumbosacral junction.
Keyphrases
- recombinant human
- minimally invasive
- escherichia coli
- hyaluronic acid
- randomized controlled trial
- coronary artery bypass
- tissue engineering
- spinal cord
- systematic review
- bone mineral density
- soft tissue
- surgical site infection
- biofilm formation
- bone loss
- bone regeneration
- acute coronary syndrome
- coronary artery disease
- young adults